Published in J Immunol Methods on January 01, 1977
Cellular collaboration in the production of human leucocyte migration inhibition factor. Immunology (1978) 0.91
An in vitro assessment of cellular and humoral immune function in pulmonary tuberculosis: correction of defective neutrophil motility by ascorbate, levamisole, metoprolol and propranolol. Clin Exp Immunol (1980) 0.81
Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen. Infect Immun (1981) 0.79
Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T). Immunology (1980) 0.79
Effect of immunoglobulin G on the responsiveness of human neutrophils to soluble staphylococcal protein A-induced neutrophil migration inhibition factor from T-lymphocytes. Infect Immun (1980) 0.79
Impaired response of neutrophils to a lymphokine by sera from patients with connective tissue disease. Infect Immun (1983) 0.78
Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51
Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16
Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science (1984) 3.84
Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature (1985) 3.73
Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42
SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25
Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res (1973) 2.11
Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89
Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids. J Natl Cancer Inst (1973) 1.79
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells. Proc Natl Acad Sci U S A (1986) 1.76
Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood (1986) 1.74
DNA damage and repair in female C57BL/10 mice of different ages injected with the carcinogen benzo[a]pyrene-trans-7,8-diol. Mutat Res (1989) 1.68
Multiple sclerosis: association with HL-A3. Tissue Antigens (1972) 1.65
Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood (1987) 1.63
Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med (1972) 1.63
Influence of race on kidney transplant survival. Transplant Proc (1977) 1.58
HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56
Empirical validation of the Essen-Möller probability of paternity. Am J Hum Genet (1986) 1.56
Migration enhancement factor: a new lymphokine. Proc Natl Acad Sci U S A (1974) 1.55
Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. J Immunol (1986) 1.46
Twins with two different fathers identified by HLA. N Engl J Med (1978) 1.43
Genetics of four new HL-A specificities in the Caucasian and Negro populations. Transplant Proc (1971) 1.38
Defective monocyte function in patients with genitourinary carcinoma. J Natl Cancer Inst (1975) 1.33
Serotyping for homotransplantation. IX. Evaluation of leukocyte antigen matching with the clinical course and rejection types. Transplantation (1967) 1.32
Serotyping for homotransplantation. XVI. Analysis of kidney transplants from unrelated donors. N Engl J Med (1968) 1.31
Maternal-fetal incompatibility. I. Incidence of HL-A antibodies and possible association with congenital anomalies. Transplantation (1970) 1.28
Defective T cell function in atopic dermatitis. J Allergy Clin Immunol (1976) 1.26
Behavior abnormalities and poor school performance due to oral theophylline use. Pediatrics (1986) 1.26
National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs. N Engl J Med (1991) 1.23
Effect of sensorineural hearing loss on loudness discomfort level and most comfortable loudness judgments. J Speech Hear Res (1978) 1.21
Public determinants of HLA indicated by pregnancy antibodies. Transplantation (1986) 1.20
Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood (1990) 1.19
HL-A haplotypes of 32 diseases. Transplant Rev (1975) 1.18
Identification of unresponsive kidney-transplant recipients. Lancet (1972) 1.16
A modified agarose method for detection of migration inhibitory factor and delineation of its antigen dependency. Int Arch Allergy Appl Immunol (1973) 1.14
Metaproterenol and theophylline in asthmatic children. Ann Allergy (1980) 1.13
Interaction analysis of selective and nonselective cell-mediated cytotoxicity. J Natl Cancer Inst (1976) 1.13
Leucocyte antigens and disease. I. Association of HL-A2 and chronic glomerulonephritis. Br Med J (1969) 1.12
Serotyping for homotransplantation. XII. Occurrence of cytotoxic antibodies following kidney transplantation in man. Transplantation (1968) 1.11
Neutrophil migration-inhibition activity produced by a unique T lymphoblast cell line. J Lab Clin Med (1979) 1.11
Calculations on long-term graft and patient survival in human kidney transplantation. Transplant Proc (1977) 1.10
A simplified method for lymphocyte separation. Vox Sang (1972) 1.10
Serotyping for homotransplantation. 23. Analysis of kidney transplants from parental versus sibling donors. Transplantation (1969) 1.09
Survival and disease patterns in C57BL/6J mice subjected to undernutrition. Exp Gerontol (1980) 1.07
Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. J Immunol (1996) 1.07
Association of HLA antigen a9 with progressive systemic sclerosis (scleroderma). Tissue Antigens (1978) 1.07
Autolymphocytotoxins following immunization by pregnancy, transplantation, and disease. Tissue Antigens (1971) 1.07
Evaluation of Belzer and Collins kidney-preservation methods. Lancet (1973) 1.06
Joint report of the Second International Workshop on Canine Immunogenetics. Transplant Proc (1976) 1.05
The easurement of bronchial wall components. Am Rev Respir Dis (1968) 1.04
Serotyping for homotransplantation. XXV. Evidence for three HL-A subloci. Transplant Proc (1969) 1.04
HL-A and kidney transplants: reexamination. Transplantation (1974) 1.03
Comparison of kidney transplant survival among transplant centers. Transplantation (1975) 1.03
The effect of dietary restriction of varying duration on survival, tumor patterns, immune function, and body temperature in B10C3F1 female mice. J Gerontol (1983) 1.02
Effect of theophylline on gastroesophageal reflux in normal adults. J Allergy Clin Immunol (1981) 1.01
HL-A antigens in solid tumors. Cancer Res (1973) 0.99
A single mutation hypothesis for multiple sclerosis based on the HL-A system. Neurology (1976) 0.97
Neutrophil migration inhibition factor from T lymphocytes (NIF-T): a new lymphokine. Clin Immunol Immunopathol (1979) 0.97
Preliminary studies on the thermal environment of low-birth-weight infants. J Pediatr (1973) 0.97
Serotyping for homotransplantation. XX. Selection of recipients for cadaver donor transplants. N Engl J Med (1968) 0.97
Dominant effect of histocompatibility on ten-year kidney transplant survival. Transplantation (1988) 0.95
B-lymphocyte alloantigens in Caucasians. J Exp Med (1976) 0.95
Immunodeficiency following allogeneic bone marrow transplantation. Transplant Proc (1978) 0.95
Studies on specificity of cell-mediated immunity to human tumors. J Natl Cancer Inst (1974) 0.94
Intact humoral and cell-mediated immunity in chronic marijuana smoking. J Allergy Clin Immunol (1976) 0.94
Blood transfusions and unresponsiveness to HL-A. Transplantation (1973) 0.93
Posterior subcapsular cataracts: posttransplantation in children. Ann Surg (1975) 0.93
Cadaver-kidney transplant failures at one month. N Engl J Med (1974) 0.91
Deduction of 2140 HL-A haplotypes and segregation analysis in 535 families. Transplant Proc (1973) 0.91
Cellular collaboration in the production of human leucocyte migration inhibition factor. Immunology (1978) 0.91
Serotyping for homotransplantation. XI. Group classification based on posterior probabilities. Transplantation (1967) 0.90
The effect of zero HLA class I and II mismatching in cyclosporine-treated kidney transplant patients. Transplantation (1987) 0.90
Design strategies in multiple sclerosis clinical trials. The Cyclosporine Multiple Sclerosis Study Group. Ann Neurol (1994) 0.90
The natural history and response to therapy of chronic urticaria and angioedema. Ann Allergy (1989) 0.90
Serotyping for homotransplantation. XVII. Preliminary studies of HL-A subunits and alleles. Transplantation (1968) 0.89
HLA association studies in black sarcoidosis patients. Tissue Antigens (1978) 0.89
A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis. Neurology (1989) 0.89
Prolonged survival of second human kidney transplants. Science (1972) 0.89
Increased frequency of HL-A10 in pemphigus vulgaris. Arch Dermatol (1973) 0.88
Cyclophosphamide 'pulses' in chronic progressive multiple sclerosis. A preliminary clinical trial. Arch Neurol (1987) 0.88
Neutrophil migration inhibition factor from T lymphocytes (NIF-T): partial purification by antibody affinity chromatography and further characterization. Clin Immunol Immunopathol (1982) 0.88
Calculation of probability of paternity using DNA sequences. Am J Hum Genet (1988) 0.88
Factors important in 10-year kidney transplant survival. Clin Transpl (1986) 0.88
DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus. J Immunol (1995) 0.86
Reduction of accelerated failures by transfusion. Transplant Proc (1982) 0.86
Body composition in chronic obstructive pulmonary disease. Am Rev Respir Dis (1968) 0.86
Localization of an Fc-binding reactivity to the constant region of human IgG4. Implications for the pathogenesis of rheumatoid arthritis. J Immunol (1995) 0.86
Sinus disease in children with respiratory allergy. J Allergy Clin Immunol (1978) 0.86
Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients. Transplantation (1981) 0.85
Lymphocyte response to IgG in patients with ankylosing spondylitis and their families. Clin Exp Immunol (1976) 0.85
Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease. Am J Dis Child (1976) 0.84
Blood transfusions and kidney transplants: remaining controversies. Transplant Proc (1981) 0.84
Wegener's granulomatosis in the elderly. Arthritis Rheum (1986) 0.84
Neural mechanism in induction of dioestrus and tumour in the androgen sterile rat. Nature (1967) 0.84
Clinical kidney transplants. Cell Immunol (1981) 0.83
Lymphocyte transformation induced by human granulocytes. Transplantation (1975) 0.83
Alternatives to randomized clinical trials. Neurology (1988) 0.83
Effect of HLA typing and transfusions on cyclosporine-treated renal allograft recipients. N Engl J Med (1984) 0.83